[{"Assets_0_Q3_USD":1405756000.0,"CommonStockSharesConverted_0_Q3_shares":45785000.0,"CommonStockSharesOutstanding_0_Q3_shares":45785000.0,"EarningsPerShareBasic_1_Q3_USD":-1.73,"EarningsPerShareBasic_3_Q3_USD":-5.14,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-185174000.0,"NetIncomeLossConverted_1_Q3_USD":-78805000.0,"NetIncomeLossConverted_3_Q3_USD":-218415000.0,"RevenuesConverted_1_Q3_USD":7711000.0,"RevenuesConverted_3_Q3_USD":31259000.0,"StockholdersEquity_0_Q3_USD":1141318000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171101"}]